|Description||(R)-CPP, a piperazine derivative, has been found to be an effective NMDA receptor antagonist.|
|Purity||≥95% by HPLC|
7-Chlorokynurenic acid is a water-soluble and very potent NMDA receptor antagonist acting at the strychnine-insensitive glycine binding site. It is also a poten...
LY 257883, also known as PPPA, is a competitive NMDA receptor antagonist which displays moderate selectivity for NR2A-containing receptors. Ki values are 0.13μM...
Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA receptors.It is also a CYP2B6 and...
Lanicemine, also know as AZD6765, has been to be a NMDA receptor antagonist that was once studiedd as a neuroprotective agent which was discontinued in 2007 and...
Ifenprodil is an NMDA receptor antagonist and acts at the polyamine site. It is also an α2 adrenergic receptor ligand. It is selective for σ2 ligand over σ1 sit...
Gamma-L-glutamyl-L-glutamic acid is a dipeptide that plays a role in cellular metabolism. It activates N-methyl-D-aspartate (NMDA) receptors in rats.
LY-221501, a piperidine derivative, has been found to be a NMDA receptor antagonist.
CGP 37849 is a potent, selective and competitive NMDA receptor antagonist (Ki = 35 nM). CGP 37849 exhibits an anticonvulsant effect following oral administratio...